Orange Book product · Generic (ANDA)
ANASTROZOLE
ANASTROZOLE
At a glance
Jul 15, 2011
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 15, 2011
15 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ANASTROZOLE
Strength
1MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 091177
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ANASTROZOLE
- 1995ARIMIDEXBrand (NDA)
NDA 020541 · ANI PHARMS
- 2020ANASTROZOLEGeneric (ANDA)
ANDA 212434 · EUGIA PHARMA
- 2018ANASTROZOLEGeneric (ANDA)
ANDA 206037 · BEIJING YILING
- 2012ANASTROZOLEGeneric (ANDA)
ANDA 091242 · IMPAX LABS INC
- 2012ANASTROZOLEGeneric (ANDA)
ANDA 200654 · APOTEX INC
- 2011ANASTROZOLEGeneric (ANDA)
ANDA 091331 · CHARTWELL MOLECULAR
- 2010ANASTROZOLEGeneric (ANDA)
ANDA 090568 · ACCORD HLTHCARE
- 2010ANASTROZOLEGeneric (ANDA)
ANDA 090732 · CHARTWELL RX
- 2010ANASTROZOLEGeneric (ANDA)
ANDA 091164 · CIPLA
- 2010ANASTROZOLEGeneric (ANDA)
ANDA 090088 · FRESENIUS KABI USA
- 2010ANASTROZOLEGeneric (ANDA)
ANDA 078485 · HIKMA
- 2010ANASTROZOLEGeneric (ANDA)
ANDA 078944 · KENTON
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
